These findings further support the added value of the combination therapy, in which the peripheral antagonism of thyroid hormone action provided by L-carnitine appears to contribute, beyond the standard inhibitory effect of MMI, to a partial alleviation of several hyperthyroidism-related symptoms. Here, TG is linked to hyperthyroidism.